Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas D Ross

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Molecular Pharmacology|November 29, 2007
Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cellsHonggang Wang, Eun-Woo Lee, Lin Zhou, et al.
Archives of Biochemistry and Biophysics|May 4, 2007
Mechanisms of resistance and adaptation to thapsigargin in androgen-independent prostate cancer PC3 and DU145 cellsDong I Lee, Carlota Sumbilla, Myounghee Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patientsTakeo Nakanishi, Judith E Karp, Ming Tan, et al.
Cancer Research|May 19, 2006
Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usageTakeo Nakanishi, Kimberly J Bailey-Dell, Bret A Hassel, et al.
Cancer Chemotherapy and Pharmacology|January 13, 2006
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecanAnshul Gupta, Yang Dai, R Robert Vethanayagam, et al.
The Journal of Biological Chemistry|September 4, 2016
Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-βPadmaja Gade, Amy S Kimball, Angela C DiNardo, et al.
Cancer Research|June 18, 2003
Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecinRajeev Rajendra, Murugesan K Gounder, Ahamed Saleem, et al.
Biochimica Et Biophysica Acta|November 6, 2013
Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1Yi Xie, Karthika Natarajan, Kenneth S Bauer, et al.
The Journal of Biological Chemistry|March 27, 2004
The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with hemePartha Krishnamurthy, Douglas D Ross, Takeo Nakanishi, et al.
Cancers|February 10, 2021
Metformin and Androgen Receptor-Axis-Targeted (ARAT) Agents Induce Two PARP-1-Dependent Cell Death Pathways in Androgen-Sensitive Human Prostate Cancer CellsYi Xie, Linbo Wang, Mohammad A Khan, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Molecular Pharmacology|November 29, 2007
Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cellsHonggang Wang, Eun-Woo Lee, Lin Zhou, et al.
Archives of Biochemistry and Biophysics|May 4, 2007
Mechanisms of resistance and adaptation to thapsigargin in androgen-independent prostate cancer PC3 and DU145 cellsDong I Lee, Carlota Sumbilla, Myounghee Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patientsTakeo Nakanishi, Judith E Karp, Ming Tan, et al.
Cancer Research|May 19, 2006
Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usageTakeo Nakanishi, Kimberly J Bailey-Dell, Bret A Hassel, et al.
Cancer Chemotherapy and Pharmacology|January 13, 2006
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecanAnshul Gupta, Yang Dai, R Robert Vethanayagam, et al.
The Journal of Biological Chemistry|September 4, 2016
Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-βPadmaja Gade, Amy S Kimball, Angela C DiNardo, et al.
Cancer Research|June 18, 2003
Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecinRajeev Rajendra, Murugesan K Gounder, Ahamed Saleem, et al.
Biochimica Et Biophysica Acta|November 6, 2013
Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1Yi Xie, Karthika Natarajan, Kenneth S Bauer, et al.
The Journal of Biological Chemistry|March 27, 2004
The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with hemePartha Krishnamurthy, Douglas D Ross, Takeo Nakanishi, et al.
Cancers|February 10, 2021
Metformin and Androgen Receptor-Axis-Targeted (ARAT) Agents Induce Two PARP-1-Dependent Cell Death Pathways in Androgen-Sensitive Human Prostate Cancer CellsYi Xie, Linbo Wang, Mohammad A Khan, et al.
Pageof 6